...
首页> 外文期刊>Contraception >Provider acceptability of Sayana? Press: Results from community health workers and clinic-based providers in Uganda and Senegal
【24h】

Provider acceptability of Sayana? Press: Results from community health workers and clinic-based providers in Uganda and Senegal

机译:提供商对Sayana的接受程度?新闻:乌干达和塞内加尔的社区卫生工作者和诊所提供者的结果

获取原文
获取原文并翻译 | 示例

摘要

Background Sayana? Press (SP), a subcutaneous formulation of depot medroxyprogesterone acetate (DMPA) in Uniject?, has potential to be a valuable innovation in family planning (FP) because it may overcome logistic and safety challenges in delivering intramuscular DMPA (DMPA IM). However, SP's acceptability is unknown. We measured acceptability of SP among clinic-based providers (Senegal only) and community health workers. Study design This open-label observational study was conducted in clinics in three districts in Senegal and community-based services in two districts in Uganda. Providers administered SP to clients seeking reinjection of DMPA IM. We conducted in-depth interviews with 86 providers (52 in Senegal, 34 in Uganda) to assess their experiences providing SP to clients. Results Almost all providers (84/86; 98%) preferred SP over DMPA IM. The main reason Uganda providers preferred SP was the prefilled/all-in-one design made preparation and administration easier and faster. Some providers thought the SP all-in-one feature may decrease stock outs (DMPA IM requires syringe and vial). Providers also felt clients preferred the shorter SP needle because it is less intimidating and less painful. Similarly, the main reasons Senegal providers preferred SP were its characteristics (prefilled/all-in-one) and client preference (especially less pain). They also saw a potential to increase access to FP, especially through community-based distribution. Providers from both countries reported SP introduction would be enhanced through client counseling and community engagement. Providers also said SP must be accessible, affordable and in stock. Conclusion Almost all providers preferred SP over DMPA IM. Provider recommendations should be considered during SP introduction planning. Implications We found that SP was acceptable to both clinic-based FP providers and community health workers. Providers' positive attitudes towards SP may facilitate introduction and uptake of this method.
机译:背景Sayana? Press(SP)是Uniject?中醋酸甲羟孕酮(DMPA)的皮下制剂,具有潜在的计划生育(FP)创新价值,因为它可以克服肌肉DMPA(DMPA IM)的逻辑和安全挑战。但是,SP的可接受性未知。我们测量了诊所提供者(仅塞内加尔)和社区卫生工作者对SP的可接受性。研究设计这项开放标签的观察性研究是在塞内加尔三个地区的诊所和乌干达两个地区的社区服务中进行的。提供商为寻求重新注入DMPA IM的客户管理了SP。我们对86位提供者(塞内加尔52位,乌干达34位)进行了深入访谈,以评估他们为客户提供服务提供商的经验。结果几乎所有提供商(84/86; 98%)都首选SP而不是DMPA IM。乌干达提供商选择SP的主要原因是预填充/多合一设计使准备和管理变得更加轻松和快捷。一些供应商认为SP多合一功能可能会减少缺货(DMPA IM需要使用注射器和小瓶)。提供者还认为客户更喜欢较短的SP针,因为它不那么令人恐惧和痛苦。同样,塞内加尔提供商选择SP的主要原因是其特性(预填充/多合一)和客户的偏爱(尤其是减轻了痛苦)。他们还看到了增加使用FP的潜力,特别是通过基于社区的分发。两国的提供者都报告说,通过客户咨询和社区参与将加强SP的引入。供应商还表示,SP必须易于使用,价格合理且有库存。结论几乎所有提供商都比DMPA IM更喜欢SP。 SP引入规划期间应考虑提供商的建议。启示我们发现,基于诊所的计划生育提供者和社区卫生工作者都可以接受SP。提供者对SP的积极态度可能有助于引入和采用此方法。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号